Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2003
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095667A2 Autoimmune conditions and nadph oxidase defects
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095461A1 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds
11/20/2003WO2003095460A1 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003095425A1 Cyanopyrrolidine derivatives
11/20/2003WO2003095424A1 Process for producing shogaol and intermediates for the synthesis thereof
11/20/2003WO2003095412A1 2-(α-HYDROXYPENTYL) BENZOATE AND ITS PREPARATION AND USE
11/20/2003WO2003094971A1 Cationic lipids for intracellular delivery of bioactive substances
11/20/2003WO2003094957A2 Methods of therapy for inducing tolerance
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094939A1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
11/20/2003WO2003094934A1 Medicine for prevention of and treatment for amyloidosis
11/20/2003WO2003094927A1 Method of inhibiting d-glucose absorption and d-glucose absorption inhibitor
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094917A1 Vintoperol-containing medicinal composition for transdermal administration
11/20/2003WO2003094915A1 Use of valsartan ot its metabolite to inhibit platelet aggregation
11/20/2003WO2003094913A1 Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
11/20/2003WO2003094912A1 Bislactone derivative and use thereof in medicinal composition
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094904A1 Methods and compositions for the treatment of graft failure
11/20/2003WO2003094878A1 Gallocatechin gallate-containing composition
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003WO2003094850A2 Lipid a and other carbohydrate ligand analogs
11/20/2003WO2003094840A2 Induction of antigen specific immunologic tolerance
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003073995A3 Dna vaccine against proliferating endothelial cells and methods of use thereof.
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003065970A3 Treatment of fibromyalgia and related fatigue syndromes using pindolol
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049772A3 Guanidinium transport reagents and conjugates
11/20/2003WO2003048130A3 Peroxisome proliferator activated receptor agonists
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003038110A3 7118, a human arginine n-methyltransferase family member and uses therefor
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003022804A3 Method for the preparation of crystalline tetrahydrobenzothiepines
11/20/2003WO2003020764A3 Modified factor ix
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003016506A3 Secreted proteins
11/20/2003WO2003014105A9 Bicyclic compound, production and use as hiv inhibitors
11/20/2003WO2003013512A3 Crystalline forms of fluvastatin sodium
11/20/2003WO2003012093A3 Regulator of calcineurin
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003007884A3 Method and reagents for identifying gene targets for treating breast cancer
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002069906A3 Compounds and methods for the treatment of urogenital disorders
11/20/2003WO2002067941A3 Combination comprising a signal transduction inhibitor and an epothilone derivative
11/20/2003WO2002058731A3 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003WO2002028836A9 Novel crystalline forms of a factor xa inhibitor
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002055A3 Antifungal compounds and methods of use
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030216584 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hemi-calcium essentially free of organic solvent
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216571 Tricyclic compounds
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
11/20/2003US20030216480 Reducing concentration chaperone protein; Alzheimer's disease; administering methoxychlor
11/20/2003US20030216468 Thiol-based NAALADase inhibitors
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216454 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/20/2003US20030216451 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216446 Aryl ureas as kinase inhibitors
11/20/2003US20030216445 Osteoporosis; immunosuppressants; wound healing agent
11/20/2003US20030216443 Antidiabetic agents; using mixture of enzyme inhibitors
11/20/2003US20030216438 Antimicrobial agent
11/20/2003US20030216437 Thrombin receptor antagonists
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216433 Gastrointestinal disorders; serotonine receptor antagonist; side effect reduction
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216424 Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
11/20/2003US20030216421 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 1564